Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: hotlinktuna who wrote (111185)	3/17/2004 9:22:01 AM
From: Findit	Read Replies (1) \| Respond to of 208838

NNOS - when will this one get noticed? Fine product. Wednesday March 17, 9:15 am ET LAS VEGAS--(BUSINESS WIRE)--March 17, 2004--NanoSignal Corp. (formerly MicroSignal Corp.) (OTCBB:NNOS - News) announced today that its beta testing of SLICES(TM) achieved another milestone in the company's history. Scott A. Ervin, CEO stated, "On Tuesday, March 16, 2004, our engineering team went through a full presentation of SLICES(TM) in Las Vegas. We invited a number of interested parties to view film imagery resulting from beta testing at Desert Radiologists. Using a GE Signa Version 5 with a 1.5 Tesla magnet, we made a routine sequence of a coronal image of a subject's right wrist. Using SLICES(TM), we achieved imagery that was 50% clearer in 2 minutes 36 seconds versus 5 minutes 11 seconds during normal image processing. Without SLICES(TM), the right wrist imagery was 'blurred' with undesired 'smoothing' of bone, cartilage and tendon details. "We then compared a 'Circle of Willis' Magnetic Resonance Angiography (MRA) head image on a test subject. With SLICES(TM) the image took 8 minutes 39 seconds to process versus 11 minutes 19 seconds in normal image processing. Again imagery with SLICES(TM) was superior with blood vessel anatomy in sharper configuration with less soft tissue ghosting. "Using our proprietary Film Tools software, we successfully demonstrated how to batch process patient imagery with a few clicks on the operator panel versus the old one image one-click method that must be duplicated for every picture in a panel. We also demonstrated MRI imagery using our patented 'Supercine' process that interpolates imagery resulting in greater clarity. "SLICES(TM) is fully dicom compliant with the ability to share imagery with co-located and remote PACS review stations. Images can be printed on film, and CD disk. Our paper printing costs approximately $0.50 a sheet versus around $10 for film imagery. "We will continue to work with our engineering team to complete our beta testing at Desert Radiologists in Las Vegas with our White Paper to follow. We greatly appreciate the time devoted by our engineering team and expert MRI applications consultant to this remarkable demonstration for visiting investment bankers interested in our technology and future application possibilities. "With the beta test near completion, we can quantify the benefits of SLICES(TM) on a broad spectrum of MRI devices that are currently in the field, but not performing with proficiency in comparison to newer models. With a simple $150,000 upgrade cost for SLICES(TM) versus a $2.2 million or greater purchase price of new MRI equipment, we anticipate robust market acceptance of our product." This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management's strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements, and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statement. -------------------------------------------------------------------------------- Contact: Princeton Research Inc. Michael King, 702-650-3000 -------------------------------------------------------------------------------- Source: NanoSignal Corp.